Letters to the Editor are no longer included in the main BJUI journal, but we will continue to publish them on the BJUI website as an important part of the scientific debate.

Letters Policy

  • Letters to the editor will now published in electronic form on the journal website (www.bjui.org), not in the journal itself. As such, letters are not submitted to PubMed for indexing.
  • Letters to the editor should be 500 words or less, preference is given to concise letters.
  • Writers are limited to one letter published on the website per month.
  • Letters must include full author contact details.
  • All letters will be peer-reviewed, and we reserve the right to reject letters, or to edit them if they are accepted.
  • If accepted, letters are sent to the authors of the paper being discussed, to give them the chance to make a response that will (if accepted) be published at the same time as the letter.
  • Letters will not be open for public comment; replies must be submitted by email to the Editorial Office for review.
Sir, With great interest, we read the recent article by O’Neil et al. [1], in which the authors investigated the relation between the tumour zonal origin (transition zone vs periph[...]
Sir, We read with much interest the work of Salami [1], which strengthens the evidence in favour of a mpMRI targeted biopsy (TBx) in the diagnostic work-up of patients with persist[...]
Sir, Chen et al. [1] have performed an interesting evaluation on  cumulative cancer length on prostate needle biopsy (Bx) divided by the number of biopsy cores (CCL/core) in predic[...]
Sir,  While the dual concept of operating via an infrapubic incision and using a “double breasted” tunical repair technique for ventral penile curvature is interesting, Alei et al.[...]
Sir, We were delighted to read the comment by Vasdev et al. [1]. This is an important topic relating to prostate cancer survivorship which is currently unaddressed. One of the prob[...]
Sir, We read with interest the recent ‘Article of the Month’ by Park et al. in which they concluded that multi-parametric 3T-MRI can be used to predict adverse pathological feature[...]